Longitudinal regional brain volume loss in schizophrenia: Relationship to antipsychotic medication and change in social function

Schizophrenia Research

Volumn 168, Issue 1-2, 2015, Pages 297-304

  Guo, Joyce Y ^a,b   Huhtaniska, Sanna ^c   Miettunen, Jouko ^c   Jääskeläinen, Erika ^c   Kiviniemi, Vesa ^d   Nikkinen, Juha ^d   Moilanen, Jani ^c   Haapea, Marianne ^d   Mäki, Pirjo ^{c,d,e,f,g,h,i}   Jones, Peter B ^a   Veijola, Juha ^c,d   Isohanni, Matti ^c,d   Murray, Graham K ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF OULU   (Finland)

^d OULU UNIVERSITY HOSPITAL   (Finland)

^e Länsi Pohja Healthcare District ^*  (Finland)

^f Central Ostrobothnia Hospital   (Finland)

^g Mental Health Services Joint Municipal Authority of Wellbeing in Raahe District   (Finland)

^h Mental Health Services Basic Health Care District of Kallio   (Finland)

ⁱ North Ostrobothnia Hospital District   (Finland)

Author keywords

Antipsychotic medication; Longitudinal MRI; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN REGION; BRAIN SIZE; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EXPOSURE; FEMALE; FINLAND; FOLLOW UP; FRONTAL LOBE; HANDEDNESS; HUMAN; INFERIOR FRONTAL GYRUS; LENGTH OF STAY; LINGUAL GYRUS; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; OCCUPATIONAL HEALTH; PARIETAL LOBE; PRECUNEOUS CORTEX; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SOCIAL STATUS; SUBSTANTIA INNOMINATA; SUPRAMARGINAL GYRUS; TEMPORAL LOBE; VOXEL BASED MORPHOMETRY; BRAIN; COHORT ANALYSIS; DRUG EFFECTS; IMAGE PROCESSING; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN; COHORT STUDIES; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STATISTICS, NONPARAMETRIC;

EID: 84942372098     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.06.016     Document Type: Article

References (64)

1. Andreasen N.C., Nopoulos P., Magnotta V., Pierson R., Ziebell S., Ho B.C. Progressive brain change in schizophrenia: A prospective longitudinal study of first-episode schizophrenia. Biol. Psychiatry 2011, 70:672-679.
2. Asami T., Bouix S., Whitford T.J., Shenton M.E., Salisbury D.F., McCarley R.W. Longitudinal loss of gray matter volume in patients with first-episode schizophrenia: DARTEL automated analysis and ROI validation. NeuroImage 2012, 59:986-996.
3. Benes F.M., McSparren J., Bird E.D., SanGiovanni J.P., Vincent S.L. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch. Gen. Psychiatry 1991, 48:996-1001.
4. Bludau S., Eickhoff S.B., Mohlberg H., Caspers S., Laird A.R., Fox P.T., Schleicher A., Zilles K., Amunts K. Cytoarchitecture, probability maps and functions of the human frontal pole. NeuroImage 2014, 93(Pt 2):260-275.
5. Byun M.S., Kim J.S., Jung W.H., Jang J.H., Choi J.S., Kim S.N., Choi C.H., Chung C.K., An S.K., Kwon J.S. Regional cortical thinning in subjects with high genetic loading for schizophrenia. Schizophr. Res. 2012, 141:197-203.
6. Carr L., Iacoboni M., Dubeau M.C., Mazziotta J.C., Lenzi G.L. Neural mechanisms of empathy in humans: A relay from neural systems for imitation to limbic areas. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:5497-5502.
7. Carrington S.J., Bailey A.J. Are there theory of mind regions in the brain? A review of the neuroimaging literature. Hum. Brain Mapp. 2009, 30:2313-2335.
8. Cobia D.J., Smith M.J., Wang L., Csernansky J.G. Longitudinal progression of frontal and temporal lobe changes in schizophrenia. Schizophr. Res. 2012, 139:1-6.
9. Couture S.M., Granholm E.L., Fish S.C. A path model investigation of neurocognition, theory of mind, social competence, negative symptoms and real-world functioning in schizophrenia. Schizophr. Res. 2011, 125:152-160.
10. Crespo-Facorro B., Roiz-Santianez R., Perez-Iglesias R., Pelayo-Teran J.M., Rodriguez-Sanchez J.M., Tordesillas-Gutierrez D., Ramirez M., Martinez O., Gutierrez A., de Lucas E.M., Vazquez-Barquero J.L. Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1936-1943.
11. de Bresser J., Portegies M.P., Leemans A., Biessels G.J., Kappelle L.J., Viergever M.A. A comparison of MR based segmentation methods for measuring brain atrophy progression. NeuroImage 2011, 54:760-768.
12. DeLisi L.E. The concept of progressive brain change in schizophrenia: Implications for understanding schizophrenia. Schizophr. Bull. 2008, 34:312-321.
13. DeLisi L.E., Tew W., Xie S.H., Tew W., Xie S., Hoff A.L., Sakuma M., Kushner M., Lee G., Shedlack K., Smith A.M., Grimson R. A prospective follow-up study of brain morphology and cognition in first episode schizophrenic patients. Biol. Psychiatry 1995, 38:349-360.
14. DeLisi L.E., Grimson R., Sakuma M., Tew W., Kushner M., Hoff A.L. Schizophrenia as a chronic active brain process: A study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res. Neuroimaging 1997, 74:129-140.
15. DeLisi L.E., Sakuma M., Maurizio A.M., Relja M., Hoff A.L. Cerebral ventricular change over the first 10years after the onset of schizophrenia. Psychiatry Res. 2004, 130:57-70.
16. DeLisi., L.E., Szulc K.U., Bertisch H.C., Majcher M., Brown K. Understanding structural brain changes in schizophrenia. Dialogues Clin. Neurosci. 2006, 8(1):71-78.
17. Ebdrup B.H., Skimminge A., Rasmussen H., Aggernaes B., Oranje B., Lublin H., Baare W., Glenthoj B. Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: Relationship to dose and symptoms. Int. J. Neuropsychopharmacol. 2011, 14:69-82.
18. Ebdrup B.H., Nørbak H., Borgwardt S., Glenthøj B. Volumetric changes in the basal ganglia after antipsychotic monotherapy: A systematic review. Curr. Med. Chem. 2013, 20:438-447.
19. Fiszdon J.M., Fanning J.R., Johannesen J.K., Bell M.D. Social cognitive deficits in schizophrenia and their relationship to clinical and functional status. Psychiatry Res. 2013, 205:25-29.
20. Fletcher P.C., Happe F., Frith U., Baker S.C., Dolan R.J., Frackowiak R.S., Frith C.D. Other minds in the brain: A functional imaging study of "theory of mind" in story comprehension. Cognition 1995, 57:109-128.
21. Fraguas D., Díaz-Caneja C.M., Pina-Camacho L., Janssen J., Arango C. Progressive brain changes in children and adolescents with early-onset psychosis: A meta-analysis of longitudinal MRI studies. Schizophr. Res. 2014, 10.1016/j.schres.2014.12.022.
22. Fusar-Poli P., Smieskova R., Kempton M.J., Ho B.C., Andreasen N.C., Borgwardt S. Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neurosci. Biobehav. Rev. 2013, 37:1680-1691.
23. Gallagher H.L., Happe F., Brunswick N., Fletcher P.C., Frith U., Frith C.D. Reading the mind in cartoons and stories: An fMRI study of 'theory of mind' in verbal and nonverbal tasks. Neuropsychologia 2000, 38:11-21.
24. Goldstein J.M., Goodman J.M., Seidman L.J., Kennedy D.N., Makris N., Lee H., Tourville J., Caviness V.S., Faraone S.V., Tsuang M.T. Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch. Gen. Psychiatry 1999, 56:537-547.
25. Gutiérrez-Galve L., Chu E.M., Leeson V.C., Price G., Barnes T.R., Joyce E.M., Ron M.A. A longitudinal study of cortical changes and their cognitive correlates in patients followed up after first-episode psychosis. Psychol. Med. 2015, 45(1):205-216.
26. Haapea M., Miettunen J., Veijola J., Lauronen E., Tanskanen P., Isohanni M. Non-participation may bias the results of a psychiatric survey: An analysis from the survey including magnetic resonance imaging within the Northern Finland 1966 Birth Cohort. Soc. Psychiatry Psychiatr. Epidemiol. 2007, 42:403-409.
27. Haijma S.V., Van Haren N., Cahn W., Koolschijn P.C., Hulshoff Pol H.E., Kahn R.S. Brain volumes in schizophrenia: A meta-analysis in over 18 000 subjects. Schizophr. Bull. 2013, 39:1129-1138.
28. Haug J.O. Pneumoencephalographic studies in mental disease. Acta Psychiatr. Scand. Suppl. 1962, 165:1-104.
29. Hayasaka S., Nichols T.E. Validating cluster size inference: Random field and permutation methods. NeuroImage 2003, 20:2343-2356.
30. Ho B.C., Andreasen N.C., Nopoulos P., Arndt S., Magnotta V., Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome-A longitudinal magnetic resonance imaging study early in schizophrenia. Arch. Gen. Psychiatry 2003, 60:585-594.
31. Ho B.C., Andreasen N.C., Ziebell S., Pierson R., Magnotta V. Long-term antipsychotic treatment and brain volumes: A longitudinal study of first-episode schizophrenia. Arch. Gen. Psychiatry 2011, 68:128-137.
32. Horan W.P., Green M.F., DeGroot M., Fiske A., Hellemann G., Kee K., Kern R.S., Lee J., Sergi M.J., Subotnik K.L., Sugar C.A., Ventura J., Nuechterlein K.H. Social cognition in schizophrenia, Part 2: 12-month stability and prediction of functional outcome in first-episode patients. Schizophr. Bull. 2012, 38:865-872.
33. Horga G., Bernacer J., Dusi N., Entis J., Chu K., Hazlett E.A., Haznedar M.M., Kemether E., Byne W., Buchsbaum M.S. Correlations between ventricular enlargement and gray and white matter volumes of cortex, thalamus, striatum, and internal capsule in schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 2011, 261:467-476.
34. Isohanni M., Makikyro T., Moring J., Rasanen P., Hakko H., Partanen U., Koiranen M., Jones P. A comparison of clinical and research DSM-III-R diagnoses of schizophrenia in a Finnish national birth cohort. Clinical and research diagnoses of schizophrenia. Soc. Psychiatry Psychiatr. Epidemiol. 1997, 32:303-308.
35. Jenkinson M., Beckmann C.F., Behrens T.E., Woolrich M.W., Smith S.M. FSL. NeuroImage 2012, 62:782-790.
36. Johnstone E.C., Crow T.J., Frith C.D., Husband J., Kreel L. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 1976, 308(7992):924-926.
37. Kempton M.J., Stahl D., Williams S.C., DeLisi L.E. Progressive lateral ventricular enlargement in schizophrenia: A meta-analysis of longitudinal MRI studies. Schizophr. Res. 2010, 120:54-62.
38. Khorram B., Lang D.J., Kopala L.C., Vandorpe R.A., Rui Q., Goghari V.M., Smith G.N., Honer W.G. Reduced thalamic volume in patients with chronic schizophrenia after switching from typical antipsychotic medications to olanzapine. Am. J. Psychiatry 2006, 163:2005-2007.
39. Lang D.J., Kopala L.C., Vandorpe R.A., Rui Q., Smith G.N., Goghari V.M., Lapointe J.S., Honer W.G. Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia. Am. J. Psychiatry 2004, 161:1829-1836.
40. Lieberman J.A., Tollefson G.D., Charles C., Zipursky R., Sharma T., Kahn R.S., Keefe R.S., Green A.I., Gur R.E., McEvoy J., Perkins D., Hamer R.M., Gu H., Tohen M. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch. Gen. Psychiatry 2005, 62:361-370.
41. Malhotra A., Maughan D., Ansell J., Lehman R., Henderson A., Gray M., Stephenson T., Bailey S. Choosing wisely in the UK: the Academy of Medical Royal Colleges' initiative to reduce the harms of too much medicine BMJ 350:h2308 2015.
42. Mamah D., Harms M.P., Barch D., Styner M., Lieberman J.A., Wang L. Hippocampal shape and volume changes with antipsychotics in early stage psychotic illness. Front. Psychiatry 2012, 3:96.
43. Marsden C.D. Cerebral atrophy and cognitive impairment in chronic schizophrenia. Lancet 1976, 308(7994):1079.
44. McClure R.K., Phillips I., Jazayerli R., Barnett A., Coppola R., Weinberger D.R. Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment. Psychiatry Res. 2006, 148(2-3):121-132.
45. McGlade N., Behan C., Hayden J., O'Donoghue T., Peel R., Haq F., Gill M., Corvin A., O'Callaghan E., Donohoe G. Mental state decoding v. mental state reasoning as a mediator between cognitive and social function in psychosis. Br. J. Psychiatry 2008, 193:77-78.
46. Moilanen K., Veijola J., Laksy K., Makikyro T., Miettunen J., Kantojarvi L., Kokkonen P., Karvonen J.T., Herva A., Joukamaa M., Jarvelin M.R., Moring J., Jones P.B., Isohanni M. Reasons for the diagnostic discordance between clinicians and researchers in schizophrenia in the Northern Finland 1966 Birth Cohort. Soc. Psychiatry Psychiatr. Epidemiol. 2003, 38:305-310.
47. Moncrieff J., Leo J. A systematic review of the effects of antipsychotic drugs on brain volume. Psychol. Med. 2010, 40:1409-1422.
48. Moore M.D., Nathan A.R., Elliot C., Laubach C. Encephalographic studies in mental disease. Am. J. Psychiatry 1935, 92:43-67.
49. Nakamura M., Salisbury D.F., Hirayasu Y., Bouix S., Pohl K.M., Yoshida T., et al. Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: A cross-sectional and longitudinal MRI study. Biol. Psychiatry 2007, 62:773-783.
50. Navari S., Dazzan P. Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings. Psychol. Med. 2009, 39:1763-1777.
51. Nichols T.E., Holmes A.P. Nonparametric permutation tests for functional neuroimaging: A primer with examples. Hum. Brain Mapp. 2002, 15:1-25.
52. Olabi B., Ellison-Wright I., McIntosh A.M., Wood S.J., Bullmore E., Lawrie S.M. Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol. Psychiatry 2011, 70(1):88-96.
53. Orellana G., Slachevsky A. Executive functioning in schizophrenia. Front. Psychiatry 2013, 4:35.
54. Rosso I.M., Makris N., Thermenos H.W., Hodge S.M., Brown A., Kennedy D., Caviness V.S., Faraone S.V., Tsuang M.T., Seidman L.J. Regional prefrontal cortex gray matter volumes in youth at familial risk for schizophrenia from the Harvard Adolescent High Risk Study. Schizophr. Res. 2010, 123:15-21.
55. Saijo T., Abe T., Someya Y., Sassa T., Sudo Y., Suhara T., Shuno T., Asai K., Okubo Y. Ten year progressive ventricular enlargement in schizophrenia: An MRI morphometrical study. Psychiatry Clin. Neurosci. 2001, 55:41-47.
56. Smieskova R., Fusar-Poli P., Allen P., Bendfeldt K., Stieglitz R.D., Drewe J., Radue E.W., McGuire P.K., Riecher-Rössler A., Borgwardt S.J. The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?--a systematic review. Curr. Pharm. Des. 2009, 15(22):2535-2549.
57. Smith S.M., Zhang Y., Jenkinson M., Chen J., Matthews P.M., Federico A., De Stefano N. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. NeuroImage 2002, 17:479-489.
58. Torres U.S., Portela-Oliveira E., Borgwardt S., Busatto G.F. Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysis. BMC Psychiatry 2013, 13:342.
59. van Haren N.E., Cahn W., Hulshoff Pol H.E., Schnack H.G., Caspers E., Lemstra A., Sitskoorn M.M., Wiersma D., van den Bosch R.J., Dingemans P.M., Schene A.H., Kahn R.S. Brain volumes as predictor of outcome in recent-onset schizophrenia: A multi-center MRI study. Schizophr. Res. 2003, 64:41-52.
60. van Haren N.E., Hulshoff Pol H.E., Schnack H.G., Cahn W., Mandl R.C., Collins D.L., Evans A.C., Kahn R.S. Focal gray matter changes in schizophrenia across the course of the illness: A 5-year follow-up study. Neuropsychopharmacology 2007, 32:2057-2066.
61. van Haren N.E.M., Pol H.E.H., Schnack H.G., Cahn W., Brans R., Carati I., Rais M., Kahn R.S. Progressive brain volume loss in schizophrenia over the course of the illness: Evidence of maturational abnormalities in early adulthood. Biol. Psychiatry 2008, 63:106-113.
62. van Haren N.E., Schnack H.G., Cahn W., van den Heuvel M.P., Lepage C., Collins L., Evans A.C., Hulshoff Pol H.E., Kahn R.S. Changes in cortical thickness during the course of illness in schizophrenia. Arch. Gen. Psychiatry 2011, 68:871-880.
63. Veijola J., Guo J.Y., Moilanen J.S., Jaaskelainen E., Miettunen J., Kyllonen M., Haapea M., Huhtaniska S., Alaraisanen A., Maki P., Kiviniemi V., Nikkinen J., Starck T., Remes J.J., Tanskanen P., Tervonen O., Wink A.M., Kehagia A., Suckling J., Kobayashi H., Barnett J.H., Barnes A., Koponen H.J., Jones P.B., Isohanni M., Murray G.K. Longitudinal changes in total brain volume in schizophrenia: Relation to symptom severity, cognition and antipsychotic medication. PLoS One 2014, 9:e101689.
64. Vita A., De Peri L., Deste G., Sacchetti E. Progressive loss of cortical gray matter in schizophrenia: A meta-analysis and meta-regression of longitudinal MRI studies. Transl Psychiatry 2012, 2:e190.